A new report shows older people benefit from improved physical and mental health in retirement communities, resulting in cost savings to the NHS. Findings from the independent study into healthy ageing carried out by Lancaster and Aston Universities showed that residents living within a charity’s retirement communities: · are more physically active (75% increase in exercise) · benefit from a reduced risk of falls (18%) · are less anxious (23%) · have an...
Tag: <span>Depression</span>
Post
Study recommends new ways to treat musculoskeletal pain
by University of Western Australia A new study led by The University of Western Australia has identified 11 recommendations to help health professionals and patients better manage musculoskeletal problems. The study comes after the team found many musculoskeletalproblems were not being managed effectively. Musculoskeletal conditions – including back and neck pain, osteoarthritis and shoulder pain – affect nearly 7 million Australians with around one in five visits to the doctor due...
Post
Promising new drug for treatment-resistant depression – esketamine
Treatment-resistant depression affects 1 in 3 of the estimated 16.2 million adults in the U.S. who have suffered at least one major depressive episode. For them, two or more therapies have failed and the risk of suicide is much greater. It’s a grim prognosis. The chemical structure of esketamine. The chemical structure of ketamine. As there...
Post
Why sleep is good for your arteries
Fresh evidence suggests that sleep regulates a mechanism that can help to protect arteries from hardening. The finding reinforces the notion that good-quality sleep is important for cardiovascular health. Scientists from Massachusetts General Hospital (MGH) in Boston, MA, together with colleagues from other research centers, studied the development of atherosclerosis in mice. Atherosclerosis is the...
Post
The psychiatry field is buzzing with anticipation — and hesitation — about esketamine for depression – pharmaceutical
The Food and Drug Administration is expected to decide in the coming weeks whether to approve esketamine, which would become the first major depression treatment to hit the market in decades. The psychiatry field is buzzing with excitement — and hesitation. Esketamine — developed by Johnson & Johnson and delivered as a nasal spray —...
Post
Johnson & Johnson’s nasal spray for depression wins FDA panel backing
(Reuters) – An advisory panel to the U.S. Food and Drug Administration on Tuesday voted in favor of Johnson & Johnson’s experimental nasal spray, which has a compound similar to often-abused ketamine, bringing the drug closer to approval. FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike...
Post
Cannabis use in teens raises risk of depression in young adults
While there has been a lot of focus on the role of cannabis use in psychosis, there has been less attention on whether cannabis use is associated with an increased risk of common mental health disorders, such as depression and anxiety. University of Oxford Researchers from McGill University and the University of Oxford carried out...
Post
New molecules reverse memory loss linked to depression, aging
New therapeutic molecules developed at Toronto’s Centre for Addiction and Mental Health (CAMH) show promise in reversing the memory loss linked to depression and aging. Credit: Medibulletin These molecules not only rapidly improve symptoms, but remarkably, also appear to renew the underlying brain impairments causing memory loss in preclinical models. These findings were presented today...
Post
Healthy diet can ease symptoms of depression
An analysis of data from almost 46,000 people has found that weight loss, nutrient boosting and fat reduction diets can all reduce the symptoms of depression. Dr Joseph Firth, an Honorary Research fellow at The University of Manchester and Research Fellow at NICM Health Research Institute at Western Sydney University, says existing research has been...
Post
Women twice as likely to suffer from severe depression after a stroke
New research today published in the European Journal of Neurology has found that women are twice as likely to suffer from severe depression following a stroke than men. The team of researchers from King’s College London followed the progress of symptoms over five years after stroke onset in 2,313 people (1,275 men and 1,038 women)....